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collection of FDA approved drugs
Pengfei Jiang1, Rajesh Mukthavaram1, Ying Chao1, Ila Sri Bharati1, Valentina Fogal1, Sandra Pastorino1, Xiuli Cong3,
Natsuko Nomura1, Matt Gallagher1, Taher Abbasi4, Shireen Vali4, Sandeep C Pingle1, Milan Makale1 and
Santosh Kesari1,2,3*Correction
After publishing this article [1], we noted mistake in
the spelling of co-author Rajesh Mukthavaram’s names.
The corrected co author name has been included to the
author list.
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